Contents
Current Pharmaceutical Design, Volume 17 - Number 30
Resident Cardiac Stem Cells
, 17(30): 3252 - 3257Frati C., Savi M., Graiani G., Lagrasta C., Cavalli S., Prezioso L., Rossetti P., Mangiaracina C., Ferraro F., Madeddu D., Musso E., Stilli D., Rossini A., Falco A., De Angelis A., Rossi F., Urbanek K., Leri A., Kajstura J., Anversa P., Quaini E. and Quaini F.
DOI: 10.2174/138161211797904181
The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
, 17(30): 3258 - 3270Lieven Thorrez and Maurilio Sampaolesi
DOI: 10.2174/138161211797904154
Stem Cells in Cardiovascular Regeneration: From Preservation of Endogenous Repair to Future Cardiovascular Therapies
, 17(30): 3280 - 3294Christian Templin, Nicolle Krankel, Thomas F. Luscher and Ulf Landmesser
DOI: 10.2174/138161211797904190
Mesenchymal Stromal Cells: A Promising Cell Source for the Treatment of Inflammatory Cardiomyopathy
, 17(30): 3295 - 3307C. Tschope, K. Miteva, H.-P. Schultheiss and S. Van Linthout
DOI: 10.2174/138161211797904136
Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
, 17(30): 3308 - 3327Sander F. Rodrigo, Jan van Ramshorst, Saskia L.M.A. Beeres, Jeroen J. Bax, Martin J. Schalij and Douwe E. Atsma
DOI: 10.2174/138161211797904172
Stem Cell Therapy for the Treatment of Myocardial Infarction
, 17(30): 3328 - 3340D. F. Dauwe and S. P. Janssens
DOI: 10.2174/138161211797904208
Effects of Mesenchymal Stromal Cells on Diabetic Cardiomyopathy
, 17(30): 3341 - 3347S. Van Linthout, F. Spillmann, H.-P. Schultheiss and C. Tschope
DOI: 10.2174/138161211797904163
Cardiac Cell Therapy and Bypass Surgery
, 17(30): 3348 - 3355Yeong-Hoon Choi, Boris Nasseri and Christof Stamm
DOI: 10.2174/138161211797904145
Webmaster Contact: info@benthamscience.org